Shared Gene Expression Alterations in Schizophrenia and Bipolar Disorder - Shao, Ling; Vawter, Marquis P. (Biological psychiatry (1969), 2008)
Keywords: Adult; Adult and adolescent clinical studies; AGXT2L1; antipsychotic medication; apoptosis; Biological and medical sciences; bipolar disorder; Bipolar Disorder - genetics; Bipolar Disorder - physiopathology; Bipolar disorders; BUB1B; dorsolateral prefrontal cortex; EMX2; ERBB2; Excitatory Amino Acid Transporter 2; Female; FGF2; FTH1; Gene Expression Profiling; Gene Expression Regulation - genetics; Genes, Tumor Suppressor; Genetic Variation - genetics; Glutamate Plasma Membrane Transport Proteins - genetics; Humans; IL2RA; LGALS3; MAFG; Male; Medical sciences; microarray; Middle Aged; Mood disorders; neurogenesis; Neuropharmacology; NFATC1; Nuclear Proteins - genetics; Oligonucleotide Array Sequence Analysis; Pharmacology. Drug treatments; Prefrontal Cortex - physiopathology; Psychiatric/Mental Health; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Psychoses; PVR; quantitative PCR; Reference Values; RERG; Reverse Transcriptase Polymerase Chain Reaction; Schizophrenia; Schizophrenia - genetics; Schizophrenia - physiopathology; SLC1A2; SMCY; SMO; Social Environment; SOX9; Transaminases - genetics; Transcription, Genetic - genetics; TU3A; TXNIP; quantitative PCR; SLC1A2; TU3A; apoptosis; BUB1B; schizophrenia; dorsolateral prefrontal cortex; FGF2; PVR; RERG; LGALS3; bipolar disorder; FTH1; ERBB2; neurogenesis; SOX9; antipsychotic medication; EMX2; AGXT2L1; NFATC1; microarray; SMO; IL2RA; MAFG; SMCY; TXNIP; Psychotropic; Neuroleptic; Pharmacotherapy; Schizophrenia; BUB1 B; Bipolar disorder; Basic fibroblast growth factor; Genetic determinism; Neurogenesis; Psychosis; Dorsolateral prefrontal cortex; Genetics